These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32679189)

  • 1. Special issue: Drug repurposing for cancer therapy.
    Srivastava SK
    Semin Cancer Biol; 2021 Jan; 68():1-2. PubMed ID: 32679189
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug repurposing for cancer therapy, easier said than done.
    Gonzalez-Fierro A; Dueñas-González A
    Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Drugs in Oncology: Next Steps.
    Verbaanderd C; Meheus L; Huys I; Pantziarka P
    Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing drugs in oncology: From candidate selection to clinical adoption.
    Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
    Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phyotochemical candidates repurposing for cancer therapy and their molecular mechanisms.
    Jung JH; Hwang J; Kim JH; Sim DY; Im E; Park JE; Park WY; Shim BS; Kim B; Kim SH
    Semin Cancer Biol; 2021 Jan; 68():164-174. PubMed ID: 31883914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Old drugs, new uses: Drug repurposing in hematological malignancies.
    Kale VP; Habib H; Chitren R; Patel M; Pramanik KC; Jonnalagadda SC; Challagundla K; Pandey MK
    Semin Cancer Biol; 2021 Jan; 68():242-248. PubMed ID: 32151704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems biology based drug repositioning for development of cancer therapy.
    Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
    Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
    Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
    Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing.
    El-Hachem N; Ba-Alawi W; Smith I; Mer AS; Haibe-Kains B
    Pharmacogenomics; 2017 Nov; 18(16):1469-1472. PubMed ID: 29057710
    [No Abstract]   [Full Text] [Related]  

  • 12. Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs.
    Sohraby F; Aryapour H
    Semin Cancer Biol; 2021 Jan; 68():249-257. PubMed ID: 32360530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based drug repositioning: Potential and limits.
    Adasme MF; Parisi D; Sveshnikova A; Schroeder M
    Semin Cancer Biol; 2021 Jan; 68():192-198. PubMed ID: 32032699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug rechanneling: A novel paradigm for cancer treatment.
    Kaushik I; Ramachandran S; Prasad S; Srivastava SK
    Semin Cancer Biol; 2021 Jan; 68():279-290. PubMed ID: 32437876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
    Palve V; Liao Y; Remsing Rix LL; Rix U
    Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of drugs as STAT3 inhibitors for cancer therapy.
    Thilakasiri PS; Dmello RS; Nero TL; Parker MW; Ernst M; Chand AL
    Semin Cancer Biol; 2021 Jan; 68():31-46. PubMed ID: 31711994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing of artemisinin-type drugs for the treatment of acute leukemia.
    Lu X; Efferth T
    Semin Cancer Biol; 2021 Jan; 68():291-312. PubMed ID: 32485311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What patents tell us about drug repurposing for cancer: A landscape analysis.
    Mucke HAM
    Semin Cancer Biol; 2021 Jan; 68():3-7. PubMed ID: 31546010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer Therapy.
    Gustafson DL; Fowles JS; Brown KC; Theodorescu D
    Assay Drug Dev Technol; 2015 Dec; 13(10):623-7. PubMed ID: 26690765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.